Cargando…
No long-term effects after a 3-week open-label placebo treatment for chronic low back pain: a 3-year follow-up of a randomized controlled trial
Chronic low back pain is prevalent, highly disabling, and a relevant socioeconomic health concern. Although allocated to placebo groups, patients in randomized controlled trials show significant pain relief, pointing to the relevance of placebo effects. Overcoming ethical and legal concerns related...
Autores principales: | Kleine-Borgmann, Julian, Dietz, Tim-Niklas, Schmidt, Katharina, Bingel, Ulrike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916047/ https://www.ncbi.nlm.nih.gov/pubmed/35947884 http://dx.doi.org/10.1097/j.pain.0000000000002752 |
Ejemplares similares
-
Impact of a 12-week open-label placebo treatment on headache days in episodic and chronic migraine: a study protocol for a parallel-group, multicentre, randomised controlled trial
por: Schmidt, Katharina, et al.
Publicado: (2021) -
Open-label placebo treatment does not enhance cognitive abilities in healthy volunteers
por: Hartmann, Helena, et al.
Publicado: (2023) -
Effects of open-label placebos on test performance and psychological well-being in healthy medical students: a randomized controlled trial
por: Kleine-Borgmann, Julian, et al.
Publicado: (2021) -
Impaired pain-related threat and safety learning in patients with chronic back pain
por: Schlitt, Frederik, et al.
Publicado: (2022) -
Does pain modality play a role in the interruptive function of acute visceral compared with somatic pain?
por: Kleine-Borgmann, Julian, et al.
Publicado: (2022)